Voloridge Investment Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-311,358
| Closed | -$31.7M | – | 1663 |
|
|
2023
Q2 | $31.7M | Buy |
311,358
+151,542
| +95% | +$15.5M | 0.15% | 191 |
|
|
2023
Q1 | $14.5M | Sell |
159,816
-58,031
| -27% | -$5.28M | 0.07% | 358 |
|
|
2022
Q4 | $8.28M | Sell |
217,847
-101,933
| -32% | -$3.87M | 0.05% | 486 |
|
|
2022
Q3 | $8.04M | Buy |
319,780
+100,927
| +46% | +$2.54M | 0.04% | 515 |
|
|
2022
Q2 | $6.65M | Sell |
218,853
-35,452
| -14% | -$1.08M | 0.03% | 571 |
|
|
2022
Q1 | $8.33M | Sell |
254,305
-68,281
| -21% | -$2.24M | 0.05% | 467 |
|
|
2021
Q4 | $8.51M | Buy |
+322,586
| New | +$8.51M | 0.05% | 517 |
|
|
2021
Q3 | – | Sell |
-70,990
| Closed | -$10M | – | 1938 |
|
|
2021
Q2 | $10M | Buy |
70,990
+54,301
| +325% | +$7.69M | 0.07% | 410 |
|
|
2021
Q1 | $1.66M | Buy |
+16,689
| New | +$1.66M | 0.01% | 874 |
|
|
2020
Q2 | – | Sell |
-2,880
| Closed | -$416K | – | 1572 |
|
|
2020
Q1 | $416K | Sell |
2,880
-11,652
| -80% | -$1.68M | 0.01% | 768 |
|
|
2019
Q4 | $2.97M | Buy |
+14,532
| New | +$2.97M | 0.06% | 397 |
|
|
2019
Q2 | – | Sell |
-5,272
| Closed | -$451K | – | 1167 |
|
|
2019
Q1 | $451K | Buy |
+5,272
| New | +$451K | 0.01% | 693 |
|